BioSpace News Archive

Pharm Country

Novartis survey uncovers real-world impact of immune thrombocytopenia or ITP, a rare blood disease, on patients’ quality of life

Findings from more than 1,300 patients across 13 countries showed ITP had especially high impact for many patients on emotional well-being (36%) and ability to work (28%)

June 15, 2018
·
10 min read
Pharm Country

CenTrak Reports Significant Growth in Hand Hygiene Business and an Increase in Hospital Compliance Rates

Denver Health Medical Center’s hand hygiene compliance rates jumped from approximately 40 percent to a sustained rate of over 70 percent

June 15, 2018
·
3 min read
Deals

GI Partners to Acquire and Simultaneously Combine Cord Blood Registry and California Cryobank

Highly Complementary Combination Creates the Leading Provider of Stem Cell Storage and Reproductive Tissue Services Across Three Attractive, Highly Resilient End-markets

June 15, 2018
·
3 min read
Genetown

Ra Pharmaceuticals Presents Data on Oral, Small Molecule Complement Inhibitors and Phase 2 RA101495 SC Program in PNH at the 23rd Congress of the European Hematology Association

Presentation of scientific data at the 23rd Congress of the European Hematology Association (EHA), June 14-17, 2018 in Stockholm, Sweden.

June 15, 2018
·
7 min read
Drug Development

Alnylam to Report New Clinical Results for Patisiran at the 4th Congress of the European Academy of Neurology

The results being presented at EAN add to the wealth of data from the APOLLO Phase 3 study of patisiran that provide evidence for the potential of this investigational RNAi therapeutic for the treatment of hATTR amyloidosis

June 15, 2018
·
11 min read
Drug Development

ArQule Presents Results from Ongoing Phase 1 Dose Escalation Study of its Reversible BTK Inhibitor, ARQ 531

Preliminary data from Phase 1 dose escalation trial highlights the potential of ARQ 531 to become a new therapeutic option for patients with B-cell malignancies

June 15, 2018
·
7 min read
Drug Development

X4 Presents Data from Ongoing Phase 2 Study Demonstrating Promising Activity of X4P-001-RD in Patients with WHIM Syndrome

Dose dependent increases in absolute neutrophil and lymphocyte counts observed in all patients treated with X4P-001-RD

June 15, 2018
·
6 min read
BioMidwest

Exicure, Inc. to Present at the 2018 JMP Securities Life Sciences Conference on June 21st at 11:00 a.m. EDT

A live webcast of the presentation will be available on the Events & Presentations section of Exicure’s website, where it will also be archived and available for replay following the presentation for 30 days.

June 15, 2018
·
2 min read
Drug Development

Acceleron Announces Updated Results from Ongoing Phase 2 Trials of Luspatercept in Beta-Thalassemia at the 23rd Congress of the European Hematology Association

Clinically meaningful increases in hemoglobin and reductions in red blood cell transfusion burden observed through 36 months

June 15, 2018
·
6 min read
Business

California Cryobank And Cord Blood Registry To Be Combined By GI Partners To Create A Leading Life Sciences Platform

California Cryobank announced that it has signed a definitive agreement for GI Partners

June 15, 2018
·
5 min read